SQI Diagnostics Inc V.SQD.H

Alternate Symbol(s): SQIDF

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Antibody testing: full disclosure

<< Previous

Bullboard Posts

Next >>

Post by 25Stone7859on Jan 18, 2023 9:04pm

223 Views

Post# 35232121

Antibody testing: full disclosure

Antibody testing is not currently recommended to asses immunity after COVID-19 vaccination according to the FDA as of May 19/2021. Nothing has changed in the interim. I understand the CDC and other jurisdictions have similar filings in place. That is probably why AZOVA cancelled and why SQI could only get approval from the NYSDOH and not the FDA or even Health Canada. The lack of a distribution partner in the US after many months of silence rings loud and clear. SQI's future rests with RALI-dx; RALI-fast and TOR-dx. These incredible devices will re-charge SQI and attract investors.

<< Previous

Bullboard Posts

Next >>

Odd Burger to add 40 locations in Florida